Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3675291012 | Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3676066014 | Valproic acid (as valproate semisodium) 500 mg gastro-resistant oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3676067017 | Valproic acid (as divalproex sodium) 500 mg gastro-resistant oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3364241000005119 | valproinsyre 500 mg enterotablet | da | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Danish module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) | Is a | Product containing valproic acid (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) | Is a | valproat | false | Inferred relationship | Some | ||
| Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) | Is a | Product containing valproic acid (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Valproic acid (substance) | false | Inferred relationship | Some | ||
| Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has manufactured dose form | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | false | Inferred relationship | Some | ||
| Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Valproat | false | Inferred relationship | Some | ||
| Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has manufactured dose form | Oral tablet | false | Inferred relationship | Some | ||
| Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) | Is a | Product containing valproic acid in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has manufactured dose form | Gastro-resistant oral tablet (dose form) | true | Inferred relationship | Some | ||
| Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has presentation strength numerator value | 500 | false | Inferred relationship | Some | 1 | |
| Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) | This attribute specifies the denominator unit for the presentation strength of a product. | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has presentation strength denominator value | en | false | Inferred relationship | Some | 1 | |
| Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Valproate semisodium | true | Inferred relationship | Some | 1 | |
| Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Valproic acid (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) | This attribute specifies the numerator unit for the presentation strength of a product. | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) | Count of base of active ingredient | en | false | Inferred relationship | Some | ||
| Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) | Is a | Valproic acid only product in oral dose form | true | Inferred relationship | Some | ||
| Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) | Plays role | Anticonvulsant therapeutic role (role) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR